Best peptide for healing: BPC-157, TB-500, and what the research actually shows
BPC-157 and TB-500 are the two most-discussed healing peptides. Here's what current research supports, what it doesn't, and how to evaluate them honestly.
by Editorial team
The two names that come up first
Ask any peptide forum for the best healing peptide and you'll hear two answers: BPC-157 and TB-500 (thymosin beta-4 fragment). Both have animal data suggesting faster tendon, ligament, and soft-tissue repair, and both have decades of anecdotal use in athletes and clinicians' off-label practice.
Neither is FDA-approved for general human use. Most published evidence comes from rodent injury models, with smaller observational human series and case reports filling in the picture.
BPC-157: where the evidence is strongest
BPC-157 is a 15-amino-acid fragment derived from a protective stomach protein. Animal studies consistently show faster tendon, muscle, and gut healing, plus blood-vessel formation (angiogenesis) at the injury site. Side-effect profile in animals is unusually clean.
Practical use among athletes typically involves 250 mcg subcutaneous twice daily near the injury site for 2–6 weeks. Human-grade safety data is thin but the consistency of recovery reports is hard to ignore.
TB-500: complementary, slightly different
TB-500 is a synthetic fragment of thymosin beta-4. It works on cell migration and tissue regeneration through a different pathway than BPC-157, which is why people often stack them. Half-life is longer, so dosing is typically 2 mg once or twice weekly.
TB-500 shines for systemic recovery rather than site-specific repair. Many users report sleep and general resilience improvements alongside the soft-tissue effects.